SEC Company Response from HCW Biologics Inc. (HCWB) (CIK 0001828673) (HCWB) — Aug 28, 2026

HCW Biologics Inc. (HCWB) (CIK 0001828673)
Date: Aug. 28, 2026 · CIK: 0001828673 · Accession: 0001493152-26-040624

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-298452

Date

August 31, 2026

Author

Hing Wong

Form

CORRESP

Company

HCW Biologics Inc. (HCWB) (CIK 0001828673)

Letter

VIA EDGAR AND E-MAIL Office of Life Sciences Division of Corporate Finance F. Street, N.E. Washington, DC 20549-7010 Re: HCW Biologics Inc. Registration Statement on Form S-1; Commission File No. 333-298452

Dear Mr. Campbell:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the “Company”) hereby requests that the effectiveness of the above referenced Registration Statement on Form S-1 be accelerated by the U.S. Securities and Exchange Commission to 3:00 p.m. Eastern Time on Monday, August 31, 2026, or as soon thereafter as is practicable.

The Company hereby authorizes James Groth or Jeny Zarmon of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please contact Mr. Groth at (312) 701-6830 or Ms. Zarmon at (609) 785-2918 with any questions you may have concerning this request, and please notify them when this request for acceleration has been granted.

Thank you for your courtesy and cooperation in this matter.

Very truly yours,
HCW BIOLOGICS INC.

Show Raw Text

CORRESP
1
filename1.htm

August
28, 2026

VIA
EDGAR AND E-MAIL

Tyler
Howes

Office
of Life Sciences

Division
of Corporate Finance

U.S.
Securities and Exchange Commission

100
F. Street, N.E.

Washington,
DC 20549-7010

Re: HCW
                                            Biologics Inc. Registration Statement on Form S-1;

  Commission
                                            File No. 333-298452

Dear
Mr. Campbell:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the “Company”) hereby requests
that the effectiveness of the above referenced Registration Statement on Form S-1 be accelerated by the U.S. Securities and Exchange
Commission to 3:00 p.m. Eastern Time on Monday, August 31, 2026, or as soon thereafter as is practicable.

The
Company hereby authorizes James Groth or Jeny Zarmon of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please
contact Mr. Groth at (312) 701-6830 or Ms. Zarmon at (609) 785-2918 with any questions you may have concerning this request, and please
notify them when this request for acceleration has been granted.

Thank
you for your courtesy and cooperation in this matter.

  Very truly yours,

  HCW BIOLOGICS INC.

  By:
  /s/ Hing Wong

  Hing Wong, Founder and CEO

HCW
Biologics acceleration request for S-1 August 2026

2929
N Commerce Parkway | Miramar, Florida 33025, USA | Phone 954-842-2024 | Fax 954-842-2037 |

SecProbe.io